Tactile Systems Technology (TCMD) Net Cash Flow Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 42.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -87.88% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -48.90% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 129.29% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -65.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 33.47% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | -31.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.14% |
| Dec 31, 2025 | 139.15% |
| Sep 30, 2025 | -491.34% |
| Jun 30, 2025 | -43.43% |
| Mar 31, 2025 | -14.93% |
| Dec 31, 2024 | 28.00% |
| Sep 30, 2024 | 32.39% |
| Jun 30, 2024 | 83.73% |
| Mar 31, 2024 | 29.42% |
| Dec 31, 2023 | -42.36% |
| Sep 30, 2023 | -36.18% |
| Jun 30, 2023 | 119.52% |
| Mar 31, 2023 | 51.43% |
| Dec 31, 2022 | -35.84% |
| Sep 30, 2022 | 26.30% |
| Jun 30, 2022 | 13.82% |
| Mar 31, 2022 | -59.43% |
| Dec 31, 2021 | 57.66% |
| Sep 30, 2021 | -87.34% |
| Jun 30, 2021 | 31.24% |
| Mar 31, 2021 | -39.10% |
| Dec 31, 2020 | 9.41% |
| Sep 30, 2020 | 91.08% |
| Jun 30, 2020 | 28.52% |
| Mar 31, 2020 | 43.48% |
| Dec 31, 2019 | 32.84% |
| Sep 30, 2019 | -29.27% |
| Jun 30, 2019 | 16.98% |
| Mar 31, 2019 | 67.62% |
| Dec 31, 2018 | -61.19% |
| Sep 30, 2018 | 120.57% |